What's in CHU de Reims's pipeline?

CHU de Reims has 17 drugs in our index: 4 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 10 in Phase 1.

Which companies overlap with CHU de Reims's portfolio?

Top competitors by shared drug class: Ain Shams University, Assistance Publique Hopitaux De Marseille, Diskapi Yildirim Beyazit Education and Research Hospital, Federal University of São Paulo, Korea University Guro Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/chu-de-reims.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

CHU de Reims — Portfolio Competitive Intelligence Brief

CHU de Reims pipeline: 4 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 3 Phase 2 10 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
whole blood collection	whole blood collection	marketed			Hematology/Transfusion Medicine
NMBA - cisatracurium	NMBA - cisatracurium	marketed	Non-depolarizing neuromuscular blocking agent (NMBA)	Nicotinic acetylcholine receptor at the neuromuscular junction	Anesthesiology
placebo - isotonic saline serum	placebo - isotonic saline serum	marketed
Curare (Atracurium)	Curare (Atracurium)	marketed	Non-depolarizing neuromuscular blocking agent	Nicotinic acetylcholine receptor (neuromuscular junction)	Anesthesia

Therapeutic area mix

Other · 2
Anesthesia · 1
Anesthesiology · 1
Hematology/Transfusion Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 1 shared drug class
Assistance Publique Hopitaux De Marseille · 1 shared drug class
Diskapi Yildirim Beyazit Education and Research Hospital · 1 shared drug class
Federal University of São Paulo · 1 shared drug class
Korea University Guro Hospital · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
Ostfold Hospital Trust · 1 shared drug class
St. Antonius Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for CHU de Reims:

Cite this brief

Drug Landscape (2026). CHU de Reims — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/chu-de-reims. Accessed 2026-05-16.